Evidence map›Paper›PMID 38018912›Full record

ArticleBriefings in bioinformatics2023

Characterization on the oncogenic effect of the missense mutations of p53 via machine learning.

Qisheng Pan, Stephanie Portelli, Thanh Binh Nguyen, David B Ascher

Open access · hybridAbstract read
In one paragraph

Article in Briefings in bioinformatics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Qisheng PanSchool of Chemistry and Molecular Bioscience, University of Queensland, Brisbane Queensland 4072, Australia.
Stephanie PortelliSchool of Chemistry and Molecular Bioscience, University of Queensland, Brisbane Queensland 4072, Australia.
Thanh Binh NguyenSchool of Chemistry and Molecular Bioscience, University of Queensland, Brisbane Queensland 4072, Australia.
David B AscherSchool of Chemistry and Molecular Bioscience, University of Queensland, Brisbane Queensland 4072, Australia.ORCID 0000-0003-2948-2413
Baker Heart and Diabetes Institute · AU

Funding

National Health and Medical Research Council GNT1174405Victorian Government's Operational Infrastructure Support Program
6 · The paper itself

Abstract

Dysfunctions caused by missense mutations in the tumour suppressor p53 have been extensively shown to be a leading driver of many cancers. Unfortunately, it is time-consuming and labour-intensive to experimentally elucidate the effects of all possible missense variants. Recent works presented a comprehensive dataset and machine learning model to predict the functional outcome of mutations in p53. Despite the well-established dataset and precise predictions, this tool was trained on a complicated model with limited predictions on p53 mutations. In this work, we first used computational biophysical tools to investigate the functional consequences of missense mutations in p53, informing a bias of deleterious mutations with destabilizing effects. Combining these insights with experimental assays, we present two interpretable machine learning models leveraging both experimental assays and in silico biophysical measurements to accurately predict the functional consequences on p53 and validate their robustness on clinical data. Our final model based on nine features obtained comparable predictive performance with the state-of-the-art p53 specific method and outperformed other generalized, widely used predictors. Interpreting our models revealed that information on residue p53 activity, polar atom distances and changes in p53 stability were instrumental in the decisions, consistent with a bias of the properties of deleterious mutations. Our predictions have been computed for all possible missense mutations in p53, offering clinical diagnostic utility, which is crucial for patient monitoring and the development of personalized cancer treatment.

Indexed as

Mutation, MissenseNeoplasmsHumansMachine LearningMutationTumor Suppressor Protein p53Tumor Suppressor Protein p53machine learning analysismissense mutationp53protein structure

Identifiers

PMID38018912
PMCPMC10685404
OpenAlexW4389140052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.